Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Lobe Sciences Ltd C.LOBE

Alternate Symbol(s):  LOBED

Lobe Sciences Ltd is a technology and services company that provides real estate, financial, management, IP, and branding support for the development of transformational medicine. It is working to develop effective psilocybin-based therapeutics for the treatment of mild traumatic brain injuries and post-traumatic stress disorder and devices for the efficient application of medications.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 
@ the Bell: The worst 1st half for stocks in decades
Gains in crude prices pushed futures for Canada’s main stock index higher on Monday although recession fears continued to weigh on sentiment.Canada’s competition bureau said that Rogers Communicat... read article.
@ the Bell: Energy & mining recover to lift TSX
Following a nasty session in the red, Canada’s main stock index rose more than 300 points in Friday trading. Gains were led by the energy and base metal sectors.After two brutal weeks brought... read article.
Buzz on the Bullboards: Another summer of uncertainty?
In times of uncertainty in the markets, investors tend to focus on more consistent plays.Not all investors are basking in summer vacations and backyard barbeques. For those who are still plugged... read article.

New Press Release - Lobe Sciences Ltd. and Clearway Global LLC Enter into a Development Agreement to Manage Lobe Sciences Ltd.'s Global Regulatory and Development Strategy and its Implementation

Vancouver, British Columbia--(Newsfile Corp. - June 21, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBED) ("Lobe" or the "Company"), a Canadian Biopsychedelics company committed to discovering and developing psychedelic inspired medicines for the improvement of neurologic, brain and mental...read article.

🎫🤑🎬 FEELING BULLISH --- Phillip J Young

  rate and reply

RE:RE:RE:RE:NEWS: Roadmap for Remainder of 2022 & Early 2023 𓋼𓋺𓋼

BIG BIDS COMING IN (myself included) -- Marcin Ashley VanDyke wrote Well said !! GajjarDr wrote What is most intersting is L-130 drug. As stated in NR... "Lobe will investigate the safety and...read more

RE:RE:RE:NEWS: Roadmap for Remainder of 2022 & Early 2023 𓋼𓋺𓋼

Well said !! GajjarDr wrote What is most intersting is L-130 drug. As stated in NR... "Lobe will investigate the safety and tolerability of an oral drug candidate, L-130 (a molecular modification...read more

RE:RE:NEWS: Roadmap for Remainder of 2022 & Early 2023 𓋼𓋺𓋼

What is most intersting is L-130 drug. As stated in NR... "Lobe will investigate the safety and tolerability of an oral drug candidate, L-130 (a molecular modification of naturally occurring...read more

RE:NEWS: Roadmap for Remainder of 2022 & Early 2023 𓋼𓋺𓋼

initforthemush wrote  rate and reply

RE:NEWS: Roadmap for Remainder of 2022 & Early 2023 𓋼𓋺𓋼

initforthemush wrote  rate and reply

RE:NEWS: Roadmap for Remainder of 2022 & Early 2023 𓋼𓋺𓋼

.  rate and reply

RE:RE:NEWS: Roadmap for Remainder of 2022 & Early 2023 𓋼𓋺𓋼

What was the stock price before the recent share split? The Companies twitter page only has 1000 followers; a media endeavor would be a great idea for company to get more public attention.  rate and reply

RE:NEWS: Roadmap for Remainder of 2022 & Early 2023 𓋼𓋺𓋼

Looks like it's going to run soon  rate and reply

RE:NEWS: Roadmap for Remainder of 2022 & Early 2023 𓋼𓋺𓋼

i read the news release. Doesn't mention much about 2023 but this company definitely has major potential... I wonder how FDA meeting will be in 3rd Q of 2022. They did a share split recently which...read more

RE:NEWS: Roadmap for Remainder of 2022 & Early 2023 𓋼𓋺𓋼

i read the news release. Doesn't mention much about 2023 but this company definitely has major potential... I wonder how FDA meeting will be in 3rd Q of 2022. They did a share split recently which...read more

RE:NEWS: Roadmap for Remainder of 2022 & Early 2023 𓋼𓋺𓋼

i read the news release. Doesn't mention much about 2023 but this company definitely has major potential... I wonder how FDA meeting will be in 3rd Q of 2022. They did a share split recently which...read more

RE:NEWS: Roadmap for Remainder of 2022 & Early 2023 𓋼𓋺𓋼

What a great cheap mushroom play!!  Thanks for the info    rate and reply

NEWS: Roadmap for Remainder of 2022 & Early 2023 𓋼𓋺𓋼

Newsfile Corp. - June 14, 2022) - Lobe Sciences Ltd. (CSE: LOBE) Lobe is preparing a pre-IND meeting request with the US Food and Drug Administration (FDA) to confirm its regulatory strategy...read more

Publication of PCT Patent Application

"Methods, Compositions and Devices for Treating Mild Traumatic Brain Injury, Post Traumatic Stress Disorder and Mild Traumatic Brain Injury with Post Traumatic Stress Disorder" Vancouver...read more

RE:Lobe will have some money soon...

It's more ownership percentage than anything. Lobe can't own more than 9% as they would have controlling interest and they don't wantr that. So they are dumping free shares that IONIC...read more

Lobe will have some money soon...

thier 23mil sale of cowlitz in IONIC shares is now worth 4mil.......  they are liquidating their IONIC shares so they can fund Lobe initiatives.  rate and reply

$LOBE management is liquidating their only Tangible asset!!!

Very sad to see $LOBE liquidating their ownership of their top 5 washington Cannabis operator at a fraction of its market value. Shareholders need to become vocal and stop this mess.    rate and reply

6 New Advisors

Companies pile on the consulting fees paid for 1 but 6 woohoo, watch the dilution go insane... and then the r/s, rinse and repeat.  This is crazy....goodbye.  rate and reply